We also found that SorLA, along with α-smooth muscle actin (αSMA) and PAI-1, is upregulated in lung tissue from patients with end-stage lung fibrosis (predominantly IPF) versus healthy controls (Figure 4, B–D). Here, SORL1 is linked to idiopathic pulmonary fibrosis.